Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Aspen Aerogels Sees FY2025 GAAP EPS $(3.86)-$(3.73) vs $(2.82) Est; Sees Sales $297M-$317M vs $296.517M Est

Author: Benzinga Newsdesk | August 07, 2025 05:39am

Second Half of 2025 Financial Outlook

Aspen's second half of 2025 Outlook is as follows:

($ in millions, except per share amounts – figures may not total due to rounding)
Metric	H1 2025 Actuals	H2 2025 Outlook	FY 2025 Outlook
Revenue	157	140 - 160	297 - 317
Net Income (Loss)	(310)	(7) - 3	(317) – (307)
Earnings Per Share (Basic)	(3.78)	(0.08) – 0.04	(3.86) – (3.73)
Adjusted EBITDA	15	20 - 30	35 – 45
CAPEX*	15	10	25

*Capital Expenditures excluding costs related to the Statesboro plant project, which totaled $11.3 million in the first half of 2025

Posted In: ASPN